These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25869896)

  • 41. Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.
    Wang J; Qie Y; Liu W; Wang H
    Hum Vaccin Immunother; 2012 Dec; 8(12):1869-74. PubMed ID: 22906934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
    Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
    Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge.
    Esparza-González SC; Troy A; Troudt J; Loera-Arias MJ; Villatoro-Hernández J; Torres-López E; Ancer-Rodríguez J; Gutiérrez-Puente Y; Muñoz-Maldonado G; Saucedo-Cárdenas O; Montes-de-Oca-Luna R; Izzo A
    Scand J Immunol; 2012 Mar; 75(3):259-65. PubMed ID: 22010821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis.
    Ahn SK; Tran V; Leung A; Ng M; Li M; Liu J
    Mol Ther; 2018 Dec; 26(12):2863-2874. PubMed ID: 30274790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination of guinea pigs with BCGΔBCG1419c transiently reduces hematogenous spread of M. tuberculosis to the spleen.
    Aceves-Sánchez MJ; Flores-Valdez MA; Shanley C; Orme I; Bielefeldt-Ohmann H
    Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30500936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence.
    Brodin P; Majlessi L; Marsollier L; de Jonge MI; Bottai D; Demangel C; Hinds J; Neyrolles O; Butcher PD; Leclerc C; Cole ST; Brosch R
    Infect Immun; 2006 Jan; 74(1):88-98. PubMed ID: 16368961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular immune responses to recombinant Mycobacterium bovis BCG constructs expressing major antigens of region of difference 1 of Mycobacterium tuberculosis.
    Shaban K; Amoudy HA; Mustafa AS
    Clin Vaccine Immunol; 2013 Aug; 20(8):1230-7. PubMed ID: 23761657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
    Luo W; Qu Z; Zhang L; Xie Y; Luo F; Tan Y; Pan Q; Zhang XL
    Vaccine; 2018 May; 36(21):2998-3009. PubMed ID: 29681409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain.
    Lau A; Singh V; Soualhine H; Hmama Z
    Vaccine; 2017 Apr; 35(16):2060-2068. PubMed ID: 28318770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.
    Ates LS; Sayes F; Frigui W; Ummels R; Damen MPM; Bottai D; Behr MA; van Heijst JWJ; Bitter W; Majlessi L; Brosch R
    PLoS Pathog; 2018 Jun; 14(6):e1007139. PubMed ID: 29912964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.
    De Lisle GW; Wilson T; Collins DM; Buddle BM
    Infect Immun; 1999 May; 67(5):2624-6. PubMed ID: 10225931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.
    Derrick SC; Yang AL; Morris SL
    Vaccine; 2004 Dec; 23(6):780-8. PubMed ID: 15542202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.